Indefinite Lived Intangible Assets Period Increase Decrease

Name: Pfizer Indefinite Lived Intangible Assets Period Increase Decrease — Quarterly & Annual Data
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Analysis

StatementIncome Statement

SectionOther

Metric ID: other_indefinite_lived_intangible_assets_period_increase_6d255a

Product Breakdown

View all

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Tukysa	—	—	—	—	-$580.00M
Padcev	-$150.00M	-$150.00M	-$150.00M	-$150.00M	—
Total	—	—	—	—	—

Bratovi/Mektovi, Etrasimod (Velsipity), Padcev are derived from annual filings.